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ABSTRACT
Objective: The aim of this study was to evaluate the in vivo immunomodulatory activity of an aqueous and ethanolic extract of dried tubers of Eulophia 
nuda (ENA and ENE).
Methods: Effect of both the extracts was evaluated on delayed-type hypersensitivity (DTH) response, serum antibody response, and cyclophosphamide-
induced myelosuppression in Swiss albino mice.
Results: The extracts showed stimulation of DTH reaction in mice in response to T-cell dependent antigen by both ENE () and ENA (); significant 
increase in serum antibody titer at of ENA (768.01) and ENE (768.33) extract at 200 mg/kg, compared to control group (213.33); Combined treatment 
of ENA+Cytochromes P450 [CYP]-25 mg/kg and ENE+CYP-25mg/kg (50, 100, and 200 mg/kg) doses of ENA and ENE each with 25 mg/kg resulted in 
restoration of bone marrow activity as compared with CYP treatment alone.
Conclusion: Both specific and non-specific immunostimulating properties of the ENE and ENA tubers in in vivo experimental methods suggest its 
therapeutic usefulness in immunocompromised conditions.
Keywords: Eulophia nuda L., Peritoneal macrophages, Nitric oxide, Carbon clearance, Ovalbumin antibody titer.
INTRODUCTION
The immune system is known to be involved in the etiology as well as 
pathophysiological mechanisms of many diseases [1]. Ayurveda gives 
emphasis on promotion of health - A concept of strengthening host 
defenses against different diseases [2]. Rasayana plants are particularly 
recommended for the treatment of immune disorder [3], Ayurveda 
(with particular reference to plants) may play an important role in 
modern health care, particularly where satisfactory treatment is not 
available. There is need to evaluate the potential of Ayurvedic remedies 
to the advantage of counteract side effect of modern therapy and 
compare the cost-effectiveness of certain therapies vis-a-vis modern 
therapeutic schedules [4]. Development of agents capable of moving 
“patients” immune system from a state of immune deficiency to one 
or more normal function would likely to have a significant impact on 
disease and the patient it affects. Such agent would not be a cure but 
would control the manifestation and course of disease [5-7].
Eulophia nuda L., Orchidaceae family, is a perennial, terrestrial herb with 
underground tubers found in central and Southeast Asian regions. In 
India, this plant is found in the tropical Himalayas, from Nepal to Assam, 
and in Deccan from Konkan southwards. The tubers are reported to be 
used against tumors, scrofulous glands of the neck, bronchitis, blood 
disease, and as a vermifuge [8-12]. In Thailand, this orchid is used in 
traditional medicines for the treatment of skin rash. Raw tubers are 
eaten for curing rheumatoid arthritis [13]. Recently, it is reported to be 
demulcent and anthelmintic in action [14]. Underground part (tubers) 
also called as Salep is used as an aphrodisiac drug [15]. They are also 
used to treat acidity, piles, and stomach complaints [16,17].
METHODS
Plant material and preparation of extract
Fresh tubers of E. nuda L. were collected from Bhimashankar region of 
the Western Ghats in Pune district, India, in May 2012 and authenticated 
from Blatter Herbarium, St. Xavier’s College, Mumbai - 400 001. The 
voucher specimen number is 20831; specimen sample was deposited 
in the herbarium of the institute for future reference. The tubers 
were thoroughly washed cut into small pieces and dried at controlled 
temperature of 45°C and powdered. The powder was then extracted 
with boiling ethanol under soxhlation to give an ethanolic extract of 
E. nuda (ENE) and similarly with boiling water under soxhlation to give 
an aqueous extract of E. nuda (ENA). The extracts were evaporated to 
dryness. The yield of ethanolic and water extract was obtained 7.5% 
and 9% for ENE and ENA extract, respectively.
Preliminary phytochemical screening
The ENE and ENA were subjected to preliminary phytochemical 
screening [18] for the detection of various plant constituents.
Experimental animals
Swiss albino mice were obtained from National Toxicology Centre, Pune. 
The animals were acclimatized for 10 days before being used for the 
experiments. They were housed in a room with controlled temperature 
(23±20°C) and a 12-h light/12-h dark cycle. The animals were fed with 
standard pellet diet and water ad libitum.
The experimental protocols were approved by the Institutional 
Animal Ethics Committee of the National Toxicology Centre, Pune, and 
conducted according to the guidelines of the Committee for the Purpose 
of Control and Supervision on Experiments on Animals, India (Research 
project No. 159).
Acute oral toxicity studies
Acute oral toxicity studies were carried out for ENA and ENE as per 
the organization for economic cooperation and development guideline 
number 423 [19,20].
Chemicals
Ovalbumin, Freund’s complete adjuvant (FCA), and bovine serum 
albumin (BSA) were procured from Bangalore Genei, India. Streptomycin, 
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penicillin, Roswell Park Memorial Institute (RPMI) 1640 medium, and 
HEPES buffer were procured from HiMedia Pvt., Ltd., India. Fetal bovine 
serum (FBS) and phytohemagglutinin-M (PHA) were procured from 
Sigma-Aldrich (St. Louis, MO, USA). All other chemicals used were of 
analytical grade.
In vivo phagocytic activity by carbon clearance assay
Phagocytic activity of both extracts was determined as per the 
method described by Yan et al. 2007 [21]. Mice were divided into 
nine groups, of six each. The vehicle control group received (0.5% 
sodium carboxymethyl cellulose [NaCMC]). Positive control group 
received immunosin 50 mg/kg. Negative control group received 
cyclophosphamide 10 mg/kg. Mice in the treatment groups were 
administered orally ENA and ENE extracts each (50, 100, and 
200 mg/kg) suspended in vehicle daily for 20 days. Colloidal carbon 
solution, Rotring ink® (Hamburg, Germany) was diluted with normal 
saline (1:8), and injected (0.01 ml/g body weight) was through tail vein 
to each mouse 24 h after the last dose. Blood samples were drawn from 
the retro-orbital plexus under ether anesthesia at 2 and 15 min after 
injection. Blood (25 μl) was mixed with 0.1 % sodium carbonate (2 ml) 
for the lysis of erythrocytes OD was recorded at 660 nm. The phagocytic 





Where, OD1 and OD2 are the optical densities at times T1 and T2, 
respectively [22].
Immunization and treatment
Mice were divided into nine groups of six each. The vehicle control group 
received 0.5% NaCMC and positive control group received immunosin 
50 mg/kg. Negative control group received cyclophosphamide 10 mg/
kg; while mice in the treatment groups were administered with the ENA 
and ENE extract each (50, 100, and 200 mg/kg, p.o.) in vehicle daily for 
20 days. On the 14th day, the animals were immunized subcutaneously 
with ovalbumin (3 mg) dissolved in normal saline emulsified with an 
equal volume of FCA.
Delayed type hypersensitivity (DTH) response
To assess the DTH response, mice were challenged subcutaneously with 
25 μg ovalbumin in 25 μl normal saline in the left hind footpad 7 days 
after the immunization. The right hind footpad was injected with 25 μl 
vehicle and served as control. The increase in footpad thickness was 
measured 24 h after the challenge with the help of a digimatic caliper 
(Mitutoyo Corporation, Japan) [23].
Detection of serum antibody response
Blood was collected from mice through retro-orbital plexus after 7 days 
of immunization and serum was separated under centrifugation. Serum 
antibody titers for quantification of serum IgG to ovalbumin were 
estimated by ELISA as described earlier [23]. Flat bottom polystyrene 
plates were coated with 12.5 μg of ovalbumin dissolved in 100μl of 
sodium carbonate buffer (pH 9.6) at 4°C for 12 h. The coated plates 
were washed 3 times with phosphate buffer saline (0.15 M, pH 7.2) 
containing 0.05% TWEEN-20 (PBS-Tw). The wells were incubated 
with 100μl of 1% BSA in sodium carbonate buffer at 37°C for 1 h. 
Serial dilutions of mouse serum samples in PBS-Tw were prepared, and 
100μl was incubated with coated wells for 1 h at 37°C. After washing, 
diluted (1:2000) anti-mouse IgG conjugated with peroxidase (100 μl) 
was added, and the plates were incubated at 37°C for 1 h. The enzyme 
activity was determined by addition of TMB/H2O2. The enzyme reaction 
was stopped by addition of 50 μl, 8 N sulfuric acid, and the absorbance 
was measured at 450 nm. Endpoint antibody titers were expressed as 
the reciprocal of the highest dilution of the test serum samples showing 
3 times more OD as compared with control samples.
Cyclophosphamide-induced myelosuppression
This experiment was studied according to the procedure described 
earlier with some modifications [24]. Mice were divided into nine 
groups of six each. The vehicle control group received (0.5% NaCMC); 
positive control group received immunosin 50 mg/kg. Negative 
control group received cyclophosphamide 25 mg/kg, while mice in the 
treatment groups were administered with the ENA and ENE extract 
each (50, 100, and 200 mg/kg, p.o.) in vehicle daily for 19 days. On 17th, 
18th, and 19th day of study, all the animals except in the vehicle control 
group were injected with cyclophosphamide (25 mg/kg, i.p.,) 1 h after 
administration of the extract or vehicle. Blood samples were collected 
on day 20, and total blood cell count was determined using hematology 
analyzer (Arcus, Diatron, Wien Austria).
Statistical analysis
Results are expressed as mean±SEM. Data were analyzed by one-way 
ANOVA followed by Dunnett’s multiple comparisons test with p<0.05 
as the criteria for significance.
RESULTS
Extraction
The yield of ethanolic and water extract was obtained 9.5% and 11% 
for ENE and ENA, respectively. The extract showed the presence of 
phytosterols, saponins, proteins, alkaloids, glycosides, and flavonoids.
Pharmacological activity
In vivo phagocytic activity by carbon clearance assay
In vivo phagocytic activity of ENA and ENE extracts was determined by the 
carbon clearance assay in mice. The results are presented in Table 1. The 
phagocytic index (K) for ENA extract was significantly higher (p<0.05) at 
50 mg/kg (15.86%), 100 mg/kg (32.06%), and 200 mg/kg (35.47%), and 
for ENE extract was significantly higher (p<0.05) at 50 mg/kg (14.8%), 
100 mg/kg (31.9%), and 200 mg/kg (41.12%) dose levels as compared 
to control group. Positive control immunosin (50 mg/kg) showed 71.2% 
higher K compared to the control group (Fig. 4).
DTH response in ovalbumin immunized mice
To examine the effect of ENA and ENE extracts on the cellular immune 
system, its activity was investigated as DTH reaction to ovalbumin 
immunized mice. The DTH response, i.e. difference in footpad thickness 
of mice is shown in Table 1. Both aqueous and ethanolic extracts 
produced a significant increase in the DTH response to ovalbumin at all 
the tested dose levels. Increase in DTH reaction in mice in response to T 
cell-dependent antigen revealed the stimulatory effect of aqueous and 
ethanolic extract on T cells (Fig. 2). Immunosin 50 mg/kg and ENA and 
ENE 100 and 200 mg/kg (p<0.05) compared to control group.
Detection of serum antibody response to ovalbumin
Humoral response to ovalbumin was studied by ELISA antibody titer 
assay. Mice treated with different doses of the ENA and ENE extract 
showed an increase in the antibody titer in a dose-dependent manner. 
There was significant increase in serum antibody titer at 200 mg/kg 
(768.01) (p<0.05) of ENA extract compared to control group (213.33) 
and significant increase in serum antibody titer at 200 mg/kg (768.33) 
(p<0.05) of ENE extract compared to the control group (213.33) 
(Table 1). Positive control immunosin (50 mg/kg) showed (1195.00) 
(p<0.05) compared to control group (Fig. 3).
Cyclophosphamide-induced myelosuppression
There was a significant reduction (p<0.05) in total white blood cell 
(WBC) count of cyclophosphamide (25 mg/kg) treated mice (8.792 
× 103 cells/cmm) as compared to vehicle control group (13.38 × 
103 cells/cmm). Cyclophosphamide dose of 25 mg/kg caused a 
significant reduction in the WBC, red blood cell (RBC), hemoglobin, 
and platelet count. Combined treatment of ENA+cytochromes P450 
[CYP]−25 mg/kg and ENE+CYP−25 mg/kg (50, 100, and 200 mg/kg) 
doses of ENA and ENE each with 25 mg/kg resulted in the restoration of 
bone marrow activity as compared with CYP treatment alone.
DISCUSSION
Immunomodulation through stimulation or suppression may help 
in maintaining a disease-free state. Agents that activate host defense 
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mechanisms in the presence of an impaired immune responsiveness 
can provide supportive therapy to conventional chemotherapy [25]. 
There is a growing interest in identifying herbal immune modulators 
ever since their possible use in modern medicine has been suggested 
[26]. The main objective of the study was to investigate the immune 
modulatory effects of ENA and ENE.
Macrophages have been known to play an important role in the host 
protection against a wide range of tumors and microorganisms. 
Macrophages also present antigen to lymphocytes during the 
development of specific immunity and serve as supportive accessory 
cells to lymphocytes. When activated, macrophages increase the 
phagocytic activity and release various materials such as cytokines 
and reactive intermediates and then carry out non-specific immune 
responses. There has been great interest in reactive nitrogen 
intermediates, nitric oxide (NO), because of its antibacterial and 
antitumor effect [27]. NO mediates diverse functions, including 
vasodilatation, neurotransmission, and inflammation [28]. A very 
high NO production indicates increased phagocytosis and bactericidal 
activity, which is supported by the data, presented in Fig. 1. 
Macrophages play an important role in defense mechanism against 
host infection and in killing tumor cells. Higher reduction of nitroblue 
tetrazolium (NBT) dye by ENA and ENE extract represents a higher 
activity of oxidase enzyme, reflecting stimulation of phagocytes in 
proportion to intracellular killing. For lysosomal enzyme activity, the 
transformation of para-nitrophenylphosphate to colored compound 
by the acid phosphatase of the stimulated macrophages correlates 
to the extent of degranulation in phagocytosis [6,29]. Phagocytosis 
of particles by macrophages is usually accompanied by a burst of 
oxidative metabolism allowing the generation of reactive oxygen 
species which can be detected through an assay based on the reduction 
of NBT [30]. The effect of various concentrations of ENA and ENE 
extracts on the reduction of NBT dye and lysosomal enzyme activity 
response of macrophages was studied for phagocytic assay. ENA and 
ENE extracts appeared to produce phagocytic stimulation with dose-
response relationship in lysosomal enzyme activity evaluation.
Table 1: Effects of ENE and ENA on phagocytic index, DTH, and antibody titer
S. No. Treatment group (dose mg/kg) Phagocytic index (K) DTH mm (× 10−2) Antibody titer
1 Vehicle control 0.0561±0.0014 23.67±0.49 213.3±26.9
2 CYP 10 0.0264±0.0010 18.67±0.88 149.3±21.3
3 Immunosin-50 0.0960±0.0010 38.63±0.89 1195.0±170.6
4 ENA 50 0.0650±0.0025 26.33±0.76 298.7±42.6
5 ENA 100 0.0741±0.0013 29.33±0.49 341.3±53.9
6 ENA 200 0.0760±0.0021 31.67±0.49 768.6±114.5
7 ENE 50 0.0644±0.0011 26.17±0.48 341.3±53.9
8 ENE 100 0.0740±0.0014 27.83±0.45 426.7±53.9
9 ENE 200 0.0831±0.0013 29.17±0.48 768.0±114.5
DTH: Delayed-type hypersensitivity. ENE: Ethanolic extracts of E. nuda L., ENA: Aqueous extracts of E. nuda L., E. nuda: Eulophia nuda, CYP: Cytochromes P450
Table 2: Effects of ENA and ENA on total WBC, RBC count, hemoglobin concentration, and platelet count
S. No. Treatment group (dose mg/kg) Total WBC count in 
thousand (cmm)




Platelet count in 
thousands (cmm)
1 Vehicle Control 13.38±0.315 7.19±0.153 12.06±0.192 498.29±3.42
2 CYP (25) 8.792±0.206 5.88±0.105 7.81±0.302 432.43±3.71
3 (Immunosin (50)+CYP (25) 12.030±0.163 8.09±0.181 12.12±0.193 540.24±1.08
4 ENA (50)+CYP (25) 9.260±0.140 5.98±0.190 10.65±0.142 451.26±4.91
5 ENA (100)+CYP (25) 10.540±0.280 6.34±0.226 11.15±0.169 482.15±4.27
6 ENA (200)+CYP (25) 11.470±0.203 7.13±0.168 11.35±0.207 495.23±1.59
7 ENE (50)+CYP (25) 9.341±0.160 6.00±0.076 10.91±0.296 430.41±2.27
8 ENE (100)+CYP (25) 10.643±0.240 6.79±0.187 11.04±0.129 456.46±0.67
9 ENE (200)+CYP (25) 10.900±0.090 6.73±0.155 11.35±0.188 475.84±1.19
ENE: Ethanolic extracts of E. nuda L., ENA: Aqueous extracts of E. nuda L., E. nuda: Eulophia nuda, CYP: Cytochromes P450, WBC: White blood cell, RBC: Red blood cell
Fig. 1: Effects of ethanolic and aqueous extracts of Eulophia nuda 
L. on carbon clearance
Fig. 2: Effects of ethanolic and aqueous extracts of Eulophia nuda 
L. on delayed-type hypersensitivity
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Myeloperoxidase, a heme protein secreted by neutrophils and 
macrophages, which uses the oxidizing potential of H2O2 to convert 
chloride ion into hypochlorous acid (HOCl). A potent bactericidal 
agent, HOCl is a critical component of host defenses against invading 
bacteria, fungi, and viruses [7,31]. The increase in the stimulation index 
of myeloperoxidase by the exposure of ENA and ENE extracts indicates 
the enhanced defense capability of these cells to pathogenic organisms. 
The release of immune mediators from murine peritoneal macrophages 
was significantly stimulated by the exposure of the extract. Murine 
isolated peritoneal macrophages incubated with the ENA and ENE 
extracts at different concentrations ranging between 832 and 6.5 μg/ml 
for 24 h, showed significant activation of macrophages by modulating 
the secretion of various mediators including NO, lysosomal enzyme, and 
myeloperoxidase activity. This suggests that ENA and ENE extracts can 
effectively strengthen innate immunity against foreign particles [32].
The process of phagocytosis involves certain body cells, known as 
phagocytes, which ingest and removes microorganisms, malignant cells, 
inorganic particles, and tissue debris [33]. Phagocytosis and killing of 
invading microorganisms by macrophages constitute body’s primary 
line of defense. Macrophages are an integral part of the immune system, 
acting as phagocytic, microbicidal, and tumoricidal effector cells [34]. 
Fig. 4: Effects of ethanolic and aqueous extracts of Eulophia nuda L. on total white blood cell, RBC count, hemoglobin concentration, and 
platelet count
Fig. 3: Effects of ethanolic and aqueous extracts of Eulophia nuda 
L. on serum antibody response to ovalbumin
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Through interaction with lymphocytes, macrophages play an important 
role in the initiation and regulation of immune response [27]. In view 
of the pivotal role played by the macrophages, ENA and ENE extracts 
were also evaluated for it’s in vivo effect on macrophage phagocytic 
activity. The increase in carbon clearance, i.e. phagocytic index by NNA 
and ENE extracts reflects the enhancement of phagocytic function 
of mononuclear macrophage and thus non-specific immunity. This 
indicates that ENA and ENE extracts were able to activate murine 
peritoneal macrophages, and hence phagocytic assays in vitro and 
in vivo.
The effect of the ENA and ENE extracts on cell-mediated immunity 
(CMI) was evaluated through DTH reaction to ovalbumin, a T cell-
dependent antigen. CMI responses are critical to defend against 
infectious organisms, infection of foreign grafts, tumor immunity, and 
DTH reaction (Miller, 1991). Therefore, increase in DTH reaction in mice 
in response to T cell-dependent antigen revealed the stimulatory effect 
of ENE and ENA (Table 2). The T and B cell cognate interaction provides 
an optimal signal for B cell differentiation and antibody production 
toward T dependent antigen (ovalbumin) [33]. The augmentation of 
the humoral immune response to ovalbumin by ENA and ENE extracts, 
as evidenced by an increase in the antibody titer in mice indicated the 
enhanced responsiveness of T and B lymphocyte subsets, involved in 
the antibody synthesis [35].
A high degree of cell proliferation renders the bone marrow a sensitive 
target, particularly to cytotoxic drugs. In fact, bone marrow is the organ 
most affected during any immunosuppressive therapy, especially with 
cyclophosphamide. Loss of stem cells and the inability of the bone 
marrow to regenerate new blood cells results in thrombocytopenia and 
leukopenia [36,37]. Since E. nuda augmented the circulating antibody 
titer, it was thought worthwhile to evaluate its effect on peripheral 
blood count and cyclophosphamide-induced immunosuppression. 
The administration of E. nuda significantly ameliorated the total WBC 
count, RBC count, hemoglobin, and platelet count and also restored the 
myelosuppressive effects induced by cyclophosphamide (Table 2). The 
present investigation suggests that E. nuda may stimulate both cellular 
and humoral immune responses. Further studies to elucidate the exact 
immunostimulatory mechanism of E. nuda need to be explored.
CONCLUSION
The studies have demonstrated specific and non-specific 
immunostimulating properties of the ENE and ENA tubers in in vivo 
experimental methods. This suggests its therapeutic usefulness in 
immunocompromised conditions.
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